Show simple item record

dc.contributor.authorRullán, John V
dc.contributor.authorHerrera Guibert, Dionisio 
dc.contributor.authorCano-Portero, Rosa 
dc.contributor.authorMoreno, Victoria
dc.contributor.authorGodoy, Pere
dc.contributor.authorPeiró, Enrique F
dc.contributor.authorCastell, Juan
dc.contributor.authorIbañez, Consuelo
dc.contributor.authorOrtega, Arturo
dc.contributor.authorSánchez Agudo, Leopoldo
dc.contributor.authorPozo, Francisco
dc.date.accessioned2020-05-05T08:22:50Z
dc.date.available2020-05-05T08:22:50Z
dc.date.issued1996-04
dc.identifier.citationEmerg Infect Dis. 1996 Apr-Jun;2(2):125-9.es_ES
dc.identifier.issn1080-6040es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9878
dc.description.abstractBefore 1990, outbreaks of multidrug-resistanttuberculosis (MDRTB) were uncommon (1); sincethen, more than 10 outbreaks have been reported,all in hospitals and prisons in the eastern UnitedStates (2-7). Persons traditionally considered atrisk for MDRTB (foreign-born TB patients andthose inadequately treated for TB) have not beenassociated with these outbreaks. Instead, the pres-ence of patients with active TB near immunocom-promised patients in HIV-dedicated wards has ledto MDRTB-infected HIV patients whose TB casesoften go unrecognized. The patients receive inade-quate treatment in facilities without effective pro-cedures for isolating acid-fast bacilli; thesecircumstances favor nosocomial transmission.Health officials in other geographic areas whereHIV and TB are major public health threats havebeen alerted to this emerging problem, and sur-veillance systems have been designed (8).es_ES
dc.description.sponsorshipDrs. Herrera, Peiró, Castell, and Godoy have received ascholarship from the Fondo de Investigación Sanitaria delInstituto de Salud Carlos III during their 2-year epidemiologictraining period in the Field Epidemiology Training Program(Programa de Epidemiología Aplicada de Campo).es_ES
dc.language.isoenges_ES
dc.publisherCenters for Disease Control and Prevention (CDC) es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAIDS-Related Opportunistic Infections es_ES
dc.subject.meshAdult es_ES
dc.subject.meshDNA, Bacterial es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInfectious Disease Transmission, Patient-to-Professional es_ES
dc.subject.meshIsoniazid es_ES
dc.subject.meshMale es_ES
dc.subject.meshMycobacterium tuberculosis es_ES
dc.subject.meshRifampin es_ES
dc.subject.meshSpain es_ES
dc.subject.meshTuberculosis es_ES
dc.subject.meshCross Infection es_ES
dc.subject.meshDrug Resistance, Microbial es_ES
dc.subject.meshDrug Resistance, Multiple es_ES
dc.titleNosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spaines_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID8903213es_ES
dc.format.volume2es_ES
dc.format.number2es_ES
dc.format.page125-9es_ES
dc.identifier.doi10.3201/eid0202.960208es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.identifier.journalEmerging infectious diseaseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional